Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cannabinoids - search results
If you're not happy with the results, please do another search
EU and UK compliance with the novel food application for CBD isolate
Christian Hendriksen, VP of International Expansion at Mile High Labs, illustrates how they are continuing compliance with the novel food application to ensure safe and effective cannabinoids can be available to all.
COVID-19: A moment for legalising medical cannabis?
Here, Josh Smith talks us through the current pandemic and the recent history underlying the fight for legalising medical cannabis.
Medical cannabis vaporizers
Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.
EU crackdown: Novel food regulation of CBD
Here, European Union (EU) Novel Food regulations are thoroughly explored and questioned in the context of CBD in food.
Why patient advocates are key to growing CBD brands
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.
Up in smoke: Understanding knowledge gaps for cannabis edibles
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.
Cannyx Markets UK Ltd: The globalisation of the CBD industry
Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.
Setting global standards for CBD quality and compliance
At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.
The FDA’s 2020 Cannabis policy
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
Standardised extracts are the future of the CBD industry
Following the latest legislative and market trends, Ilesol Pharmaceuticals has developed a new product with a shiny future in the CBD industry.
Removing the barriers to ensure a thriving UK hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance, explains what we need to know about removing the barriers to ensure a thriving UK hemp industry.
Cannabis (hemp): The effect of terpenes in CBD full extracts
Cannabis (hemp) contains up to 150 different terpenes. They not only determine the smell, but they also have valuable properties for the body as studies show. Katharina Zedlacher, from BioBloom GmbH, discusses the effect of terpenes in CBD full extracts.
Topical Cannabis-Based Medicines (TCBM): A novel epigenetic paradigm for wound management
Dr Vincent Maida discusses his discoveries and pioneering research in the area of using Topical Cannabis-Based Medicines (TCBM) for integumentary and wound management.
Naturalis London: Providing quality CBD
Joe Seaman, Head of Client Relations at Naturalis London, tells us how the firm is providing quality CBD, trusted education and tailored consumer advice.
2020: The Global Year for the Prevention of Pain
2020 is the Global Year for the Prevention of Pain. James Boyce, Managing Editor at Pain Concern explains here why that matters.
What dosage of CBD should you use?
Savage Cabbage Ltd offer their expert advice on what dosage of CBD users should be taking and answers other often asked questions, in this in-depth article.
How can medical marijuana help people lose weight?
Michael Jacobs, marketing and creative content specialist at GotVape.com offers his insight into how medical marijuana has the potential to help people lose weight.
CBD oil revolution: Introducing what it is and why the hype?
Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
Cannabis-based medicines as a treatment for epilepsy in the UK
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
Seeding the future of the British hemp industry
Rebekah Shaman, Managing Director at British Hemp Alliance takes a close look at the future of the British hemp industry in this article.
